Aster DM Healthcare Ltd.
NSE: ASTERDM · Healthcare
Operating profit collapsed 28% YoY despite 21% revenue growth, signaling margin erosion that outweighs analyst optimism; imminent Q2…
Analyst Buy initiation with ₹910 target (+20% upside), merger creates India's largest hospital platform (39 hospitals, 10,600 beds), and stock outperformed NIFTY by 32 percentage points over 12 months.
Operating profit fell 28.24% YoY in Q3 FY26 despite 21.6% revenue growth, indicating severe margin compression or integration cost overruns that contradict synergy narrative and remain unexplained.
Free: 5 Forecasts and 5 Debates a month. Log in with your mobile number.
-
Bearish 28 Sep 2026 → now Scores 28 Oct 2026₹747.35 → ₹747.35 0.0%
Every verdict and forecast here is dated and scored when it matures — right or wrong. The first scored results publish a month after launch.
How we score →
Bullzeye Financial